GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
3,771
Funds Holding Change
+300
Funds Holding Growth
+9%
Value
$666B
Holding in Top 10
340
Top 10 Change
-75
Top 10 Growth
-18%
Value Growth
+4%
New
469
Increased
1,380
Reduced
1,775
Closed
114
Capital Inflow
$27.7B
Capital Outflow
$33.2B
Net Capital Flow
-$5.56B
Capital Flow Change
+$4.97B
Calls
$7.5B
Puts
$7.38B
Net Calls
+$125M
Put/Call Ratio
0.98